These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32641008)

  • 1. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.
    Pan ST; Zhou J; Yang F; Zhou SF; Ren T
    BMC Cancer; 2020 Jul; 20(1):634. PubMed ID: 32641008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
    Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
    Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
    Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
    Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
    Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
    Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF
    Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling.
    Chen TY; Zhou J; Li PC; Tang CH; Xu K; Li T; Ren T
    Med Oncol; 2022 Jan; 39(3):36. PubMed ID: 35059870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
    Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
    Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APE1 modulates cellular responses to organophosphate pesticide-induced oxidative damage in non-small cell lung carcinoma A549 cells.
    Thakur S; Dhiman M; Mantha AK
    Mol Cell Biochem; 2018 Apr; 441(1-2):201-216. PubMed ID: 28887667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma.
    Hao C; Liu G; Tian G
    Ther Adv Respir Dis; 2019; 13():1753466619866097. PubMed ID: 31368411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced apurinic/apyrimidinic endonuclease activity enhances the antitumor activity of oxymatrine in lung cancer cells.
    Wang Z; Xu W; Lin Z; Li C; Wang Y; Yang L; Liu G
    Int J Oncol; 2016 Dec; 49(6):2331-2340. PubMed ID: 27748797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture.
    Wang Z; Liu G; Jiang J
    Int J Oncol; 2019 Mar; 54(3):1071-1085. PubMed ID: 30664195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.
    Hou G; Bai Y; Jia A; Ren Y; Wang Y; Lu J; Wang P; Zhang J; Lu Z
    Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X; Chen Y; Shen Y; Tantai J
    Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
    Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
    Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
    Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
    Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
    Abdulrahman N; Siveen KS; Joseph JM; Osman A; Yalcin HC; Hasan A; Uddin S; Mraiche F
    J Pharm Pharmacol; 2020 Nov; 72(11):1536-1545. PubMed ID: 32667058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Rad23A plays a regulatory role in autophagy.
    Tan X; Wang HC; Liang RY; Chuang SM
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1772-9. PubMed ID: 27613096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.